Inducing and Administering Tregs to Treat Human Disease

por Perdigoto, Ana Luisa, Chatenoud, Lucienne, Bluestone, Jeffrey A., Herold, Kevan C.
Publicado 2016

β cell responses to inflammation

por Usmani-Brown, Sahar, Perdigoto, Ana Luisa, Lavoie, Nathalie, Clark, Pamela, Korah, Maria, Rui, Jinxiu, Betancur, Gabriel, Herold, Kevan C.
Publicado 2019

Response to "NLRC5 germline variants and their potential role in eliciting an immune response in patients with cancer treated with immune checkpoint inhibitors" by Xiang-Yu Meng

por Aizenbud, Lilach, Schoenfeld, David A, Caulfield, Jasmine I, Mann, Jacqueline E, Austin, Matthew R, Perdigoto, Ana Luisa, Herold, Kevan C, Kluger, Harriet M
Publicado 2023

Tet2 Controls the Responses of β cells to Inflammation in Autoimmune Diabetes

por Rui, Jinxiu, Deng, Songyan, Perdigoto, Ana Luisa, Ponath, Gerald, Kursawe, Romy, Lawlor, Nathan, Sumida, Tomokazu, Levine-Ritterman, Maya, Stitzel, Michael L., Pitt, David, Lu, Jun, Herold, Kevan C.
Publicado 2021

Immune Checkpoint Inhibitor-Induced Hypophysitis and Patterns of Loss of Pituitary Function

por Jessel, Shlomit, Weiss, Sarah A., Austin, Matthew, Mahajan, Amit, Etts, Katrina, Zhang, Lin, Aizenbud, Lilach, Perdigoto, Ana Luisa, Hurwitz, Michael, Sznol, Mario, Herold, Kevan C., Kluger, Harriet M.
Publicado 2022

Germline genetic variants are associated with development of insulin-dependent diabetes in cancer patients treated with immune checkpoint inhibitors

por Caulfield, Jasmine I, Aizenbud, Lilach, Perdigoto, Ana Luisa, Meffre, Eric, Jilaveanu, Lucia, Michalek, Dominika A, Rich, Stephen S, Aizenbud, Yariv, Adeniran, Adebowale, Herold, Kevan C, Austin, Matthew R, Kluger, Harriet
Publicado 2023

Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors

por Stamatouli, Angeliki M., Quandt, Zoe, Perdigoto, Ana Luisa, Clark, Pamela L., Kluger, Harriet, Weiss, Sarah A., Gettinger, Scott, Sznol, Mario, Young, Arabella, Rushakoff, Robert, Lee, James, Bluestone, Jeffrey A., Anderson, Mark, Herold, Kevan C.
Publicado 2018

Spectrum of Clinical Presentations, Imaging Findings, and HLA Types in Immune Checkpoint Inhibitor–Induced Hypophysitis

por Quandt, Zoe, Kim, Stephanie, Villanueva-Meyer, Javier, Coupe, Catherine, Young, Arabella, Kang, Jee Hye, Yazdany, Jinoos, Schmajuk, Gabriela, Rush, Stephanie, Ziv, Elad, Perdigoto, Ana Luisa, Herold, Kevan, Lechner, Melissa G, Su, Maureen A, Tyrrell, J Blake, Bluestone, Jeffrey, Anderson, Mark, Masharani, Umesh
Publicado 2023

Immune cells and their inflammatory mediators modify β cells and cause checkpoint inhibitor–induced diabetes

por Perdigoto, Ana Luisa, Deng, Songyan, Du, Katherine C., Kuchroo, Manik, Burkhardt, Daniel B., Tong, Alexander, Israel, Gary, Robert, Marie E., Weisberg, Stuart P., Kirkiles-Smith, Nancy, Stamatouli, Angeliki M., Kluger, Harriet M., Quandt, Zoe, Young, Arabella, Yang, Mei-Ling, Mamula, Mark J., Pober, Jordan S., Anderson, Mark S., Krishnaswamy, Smita, Herold, Kevan C.
Publicado 2022